Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Bellicum Pharmaceuticals (BLCM)

Bellicum Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BLCM
DateTimeSourceHeadlineSymbolCompany
23/02/202418:19Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:19Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:18Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:18Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:17Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:17Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:17Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:16Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:16Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:16Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:15Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:15Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:15Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:14Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:14Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
23/02/202418:12Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:BLCMBellicum Pharmaceuticals Inc
14/02/202423:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLCMBellicum Pharmaceuticals Inc
14/02/202419:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLCMBellicum Pharmaceuticals Inc
30/01/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLCMBellicum Pharmaceuticals Inc
24/01/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLCMBellicum Pharmaceuticals Inc
30/05/202321:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLCMBellicum Pharmaceuticals Inc
11/05/202321:24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BLCMBellicum Pharmaceuticals Inc
05/05/202321:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BLCMBellicum Pharmaceuticals Inc
11/04/202311:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BLCMBellicum Pharmaceuticals Inc
31/03/202321:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BLCMBellicum Pharmaceuticals Inc
14/03/202320:30GlobeNewswire Inc.Bellicum Discontinues Phase 1/2 Trials and Initiates Evaluation of Strategic AlternativesNASDAQ:BLCMBellicum Pharmaceuticals Inc
16/02/202312:30GlobeNewswire Inc.Bellicum Presents Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO GU Cancers SymposiumNASDAQ:BLCMBellicum Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:BLCM

Your Recent History

Delayed Upgrade Clock